StockComparison Logo
vs

BCTX vs MTCR

Comparison between BriaCell Therapeutics Corp - New (BCTX, Company) and Metacrine Inc (MTCR, Company).

BCTX vs MTCR - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
BCTX
$25M
Winner
MTCR
$25M
Max Drawdown
BCTX
100.00%
Winner
MTCR
97.04%
Sharpe Ratio
BCTX
-0.14
Winner
MTCR
0.62
5Y Beta
BCTX
0.00
MTCR
N/A
Industry
BCTX
Biotechnology
MTCR
N/A
P/E Ratio
BCTX
-0.32
Winner
MTCR
-0.54
PEG Ratio
BCTX
-0.00
MTCR
N/A
Debt to Equity
Winner
BCTX
0.00%
MTCR
37.20%
P/B Ratio
BCTX
N/A
MTCR
0.67

BCTX vs MTCR - Historical Returns

Returns include dividend reinvestment.

1M
Winner
BCTX
+9.68%
MTCR
+2.43%
3M
BCTX
-15.42%
Winner
MTCR
+2.41%
6M
BCTX
-21.11%
Winner
MTCR
+39.42%
1Y
BCTX
-57.77%
Winner
MTCR
+17.88%
5Y(CAGR)
BCTX
-66.65%
MTCR
N/A
10Y(CAGR)
BCTX
-53.79%
MTCR
N/A
Max(CAGR)
Winner
BCTX
-46.06%
MTCR
-66.40%

BCTX vs MTCR - Annual Returns (2010 - 2026)

Returns include dividend reinvestment.

YearBCTXMTCR
2026-52.58%N/A
2025-91.83%N/A
2024-89.42%N/A
2023+27.45%+30.13%
2022-49.83%-36.01%
2021+98.56%-91.68%
2020-53.67%-33.16%
2019-52.90%N/A
2018-56.25%N/A
2017-33.33%N/A
2016-13.74%N/A
2015+31.36%N/A
2014+115.38%N/A
2013-57.81%N/A
2012-68.61%N/A
2011-63.27%N/A
2010+5.95%N/A

BCTX vs MTCR Drawdown Comparison

The maximum drawdown for BCTX was -100.00%, occurring on Jun 11, 2026. This drawdown has not yet recovered.

The maximum drawdown for MTCR was -97.04%, occurring on Oct 24, 2022. This drawdown has not yet recovered.

The current BCTX drawdown is -100.00%. The current MTCR drawdown is -95.06%.

RankBCTXMTCR
#1-100.00%
May 9, 2011 - Jun 11, 2026
-97.04%
Sep 16, 2020 - Oct 24, 2022
#2-29.21%
Mar 4, 2011 - Apr 28, 2011
N/A
#3-27.53%
Oct 28, 2010 - Dec 15, 2010
N/A

Correlation

Correlation between BCTX and MTCR is -0.62 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.62
-101

Select Stocks to Compare